In 2012, the World Health Assembly established the Member State Mechanism to address the issue of tackling substandard and falsified medical products in a transparent and inclusive way, from a public health perspective and expressly excluding considerations of intellectual property rights. The Member State Mechanism has a Steering Committee led by a Chairperson who is supported by 11 Vice-Chairpersons, representing the six ...
